GE HealthCare and Mayo Clinic Back MediView’s $24M Series A for AR Surgical Platform

• MediView closed a $24 million Series A round led by GE HealthCare, with participation from Mayo Clinic and Cleveland Clinic.
• Funds will drive the scale-up of FDA-cleared AR surgery tools that combine live imaging with 3D anatomical overlays.

MediView XR has raised $24 million in Series A funding from a syndicate led by GE HealthCare, with participation from Cleveland Clinic, Mayo Clinic, Edge Ventures, and JobsOhio Growth Capital Fund. The investment will support the global scale-up of MediView’s FDA-cleared augmented reality platform, which overlays 3D imaging onto the patient’s body to guide less invasive surgical procedures with greater accuracy and collaboration.

Its FDA-cleared platform enables real-time 3D visualization of patient anatomy by fusing CT scans with live ultrasound. The system uses augmented reality, giving clinicians "X-ray vision" to see internal anatomy in 3D. MediView says the platform helps clinicians target hard-to-see lesions, reduce cognitive load, and collaborate remotely during procedures.

"Our collaboration with MediView reflects a shared commitment to integrating advanced imaging with intuitive augmented reality technologies that have the potential to transform precision care," said Meraj Khan, Chief Marketing Officer, Surgical Innovations, Advanced Visualization Solutions, GE HealthCare, in an official press release. "We're proud to help lead this funding round and redefine how clinicians visualize anatomy in real-time to enhance procedural guidance and navigation."

With the new capital, MediView intends to scale adoption of its technology, grow its partnerships across the medical imaging and device ecosystem, and advance regulatory and clinical validation efforts. The company also plans to increase operational capacity to meet rising global demand for its surgical navigation solutions.

🌀 Tom’s Take:

Support from GE and Mayo sends a clear signal that major players see AR-guided surgery as ready to scale globally.

Source: PR Newswire / MediView XR